EXHIBIT 32.1

              CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
                   AS ADOPTED PURSUANT TO SECTION 906 OF
                      THE SARBANES-OXLEY ACT OF 2002


The certification set forth below is hereby made solely for
the purpose of satisfying the requirements of Section 906 of
the Sarbanes-Oxley Act of 2002 and may not be relied upon or
used for any other purposes.

In connection with the Quarterly Report of Access
Pharmaceuticals, Inc. (the "Company") on Form 10-Q for the
period ended September 30, 2003, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I,
Kerry P. Gray, President and Chief Executive Officer certify
pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906
of the Sarbanes Oxley Act of 2002, that to my knowledge (1)
the Report fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934 and (2)
the information contained in the Report fairly presents, in
all material respects, the financial condition and results of
operations of the Company.

A signed original of this written statement required by
Section 906 or other document authenticating, acknowledging or
otherwise adopting the signature that appears in typed form
within the electronic version of this written statement
required by Section 906 has been provided to the Company and
will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.

Signed at the City of  Dallas, in the State of Texas, this
14th day of November, 2003.

/s/ Kerry P. Gray
- ------------------
Kerry P. Gray
President and Chief Executive Officer